14:51:40 Europe / Stockholm

Prenumeration

2023-03-02 07:10:00

Redeye lowers its long-term estimates and fair value range on the back of the Q4 2022 report. We comment on the weak Q4 numbers and whether they reflect the underlying health of the business.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/